Phase 4Not yet recruitingAge-related condition
Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis (MINI-STAR)
- Sponsor
- Yonsei University (Academic or other)
- Enrollment
- 300 planned
- Conditions
- Atherosclerosis Cardiovascular Disease
- Interventions
- Crezet 2.5/10mg; Litorvazet 5/10mg; Baroezet 1/10mg
- Ages
- adults, older adults
- Registry
- NCT07871604
Full record on ClinicalTrials.gov
From the registry
This study aims to compare the tolerability and metabolic safety of three low-dose statin/ezetimibe combinations (rosuvastatin/ezetimibe 2.5/10 mg, atorvastatin/ezetimibe 5/10 mg, pitavastatin/ezetimibe 1/10 mg) in patients with minimal subclinical atherosclerosis identified by imaging studies (Coronary Computed Tomography Angiography, Coronary Angiography, or carotid sonography)
Primary outcomes
- discontinuation or drug change of the study drug due to intolerance
History
Primary completion expected
Started
Last registry update
Registered